Shared by



Dec 2, 2019 15:29


Swing Backside Scalping LIVE Intraday Backside First Test


Dilution but no prospectus yet -> $100m ATM F-3 (foreign S-3)

Catalysts / News / Painting the picture

-ASLAN Pharmaceuticals reports positive preliminary data from proof-of-concept study for ASLAN004 targeting Atopic Dermatitis
-ASLN also released PR about an offering taking place in the near future

Technical Analysis

-Holding 6.55 nicely in PM
-Huge fake upside and halt on the open
-Spent all day below VWAP
-Levels: 5, 5.50, 6, 6.30, 6.55, 8

Original Plan / Strategy

First Test long of 5.50 level


Only got filled my first lot but I should added another at 5.51 because I saw people get trapped in the last 10 minutes. I didn't follow my profit taking rules to keep 1/4 of the position for a bigger move (could have held for another 10 cents)

Execution detail:

Date/time Symbol Side Price Position
2019-12-02 15:29:08 ASLN buy $5.550 long
2019-12-02 15:29:53 ASLN sell $5.600 0

Leave a comment about this trade!

You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes just a few seconds to sign up, and it's free!

View plans, Sign up for free, or Log in